Rocket Pharmaceuticals - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
HomeRocket Pharmaceuticals
Rocket Pharmaceuticals logo

Rocket Pharmaceuticals

0 followers

RCKT

Performance

About Rocket Pharmaceuticals

Rocket Pharmaceuticals is a biopharmaceutical company focused on developing gene and molecular therapies to treat rare genetic diseases, with a particular emphasis on cardiac and other organ-specific conditions. The company conducts research and clinical trials globally, including programs for Danon disease and other rare cardiovascular disorders, with corporate and R&D headquarters in Cranbury, New Jersey and presence in New York. Their work aims to move gene therapies from research to approved treatments that address root causes of disease and improve patient outcomes. They also emphasize patient resources and collaboration with healthcare professionals and regulatory bodies to advance rare-disease therapeutics.

Recent News

Recent Deals

No recent deals for this company.

Key Facts

HQ Location

Cranbury, United States

Founded

2015

Employees

201 - 500

Status

Public

Website

https://rocketpharma.com